Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients

Plastic and Reconstructive Surgery

Volumn 116, Issue 1, 2005, Pages 200-204

  Zhang, Li ^b   Lin, Xiaoxi ^a   Wang, Wei ^b   Zhuang, Xing ^b   Dong, Jiasheng ^b   Qi, Zuoliang ^b   Hu, Qionghua ^b  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STEROID; VASCULOTROPIN;

ARTICLE; BLOOD LEVEL; CHILD; CONGENITAL BLOOD VESSEL MALFORMATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FREEZE THAWING; HEMANGIOMA; HUMAN; INFANT; MAJOR CLINICAL STUDY; PALPATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; STEROID THERAPY; VENOUS BLOOD;

BLOOD VESSELS; CAPILLARIES; CARDIOVASCULAR ABNORMALITIES; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 21744449141     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000170804.80834.5F     Document Type: Article

References (9)

1. Mulliken, J. B., and Glowacki, J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast. Reconstr. Surg. 69: 412, 1982.
2. Chang, J., Most, D., Bresnick, S., et al. Proliferative hemangiomas: Analysis of cytokine gene expression and angiogenesis. Plast. Reconstr. Surg. 03: 1, 1999.
3. Tan, S. T., Velickovic, M., Ruger, B. M., et al. Cellular and extracellular markers of hemangioma. Plast. Reconstr. Surg. 106: 529, 2000.
4. Folkman, J. Tumor angiogenesis. Adv. Cancer Res. 19: 331, 1974.
5. Poon, R. T. P., Fan, S. T., and Wong, J. Clinical implications of circulating angiogenic factors in cancer patients. J. Clin. Oncol. 19: 1207, 2001.
6. Folkman, J. Clinical applications of research on angiogenesis. N. Engl J. Med. 333: 1757, 1995.
7. Takahashi, Y., Tucker, S. L., Kitadai, Y., et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch. Surg. 132: 541, 1997.
8. Takahashi, K., Mulliken, J. B., Kozakewich, H. P. W., et al. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J. Clin. Invest. 93: 2357, 1994,
9. Bielenberg, D. R. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. Int. J. Oncol. 14: 401, 1999.